Keywords: |
adult; cancer chemotherapy; clinical article; aged; drug efficacy; hypophosphatemia; antineoplastic agents; liver toxicity; phase 2 clinical trial; nausea; vomiting; lung neoplasms; myalgia; kidney carcinoma; kidney neoplasms; gastrointestinal toxicity; kidney; carcinoma, renal cell; liver diseases; drug therapy; adverse drug reaction; therapy; intravenous drug administration; phosphorus; middle age; drug evaluation; n methylformamide; intoxication; restlessness; human; male; female; priority journal; support, u.s. gov't, p.h.s.; formamides
|